Insider Trading: Acura Pharmaceuticals Inc (ACUR.O)
ACUR.O on Consolidated Issue listed on NASDAQ Capital Market
2.34USD
22 May 2013
2.34USD
22 May 2013
Price Change (% chg)
$0.04 (+1.74%)
$0.04 (+1.74%)
Prev Close
$2.30
$2.30
Open
$2.33
$2.33
Day's High
$2.36
$2.36
Day's Low
$2.25
$2.25
Volume
521,659
521,659
Avg. Vol
733,484
733,484
52-wk High
$4.50
$4.50
52-wk Low
$1.06
$1.06
CARE CAPITAL II L L C
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 15 May 2013 | Sell | 50,000 | $2.20 | 6,590,815 |
| 14 May 2013 | Sell | 62,000 | $2.27 | 6,590,815 |
| 13 May 2013 | Sell | 550,000 | $2.41 | 6,590,815 |
| 12 May 2013 | Sell | 135,000 | $2.22 | 7,252,815 |
| 9 May 2013 | Sell | 62,000 | $2.16 | 7,252,815 |
| 8 May 2013 | Sell | 62,000 | $2.17 | 7,252,815 |
| 7 May 2013 | Sell | 62,000 | $2.15 | 7,511,815 |
| 6 May 2013 | Sell | 62,000 | $2.19 | 7,573,815 |
| 2 May 2013 | Sell | 83,252 | $2.27 | 7,573,815 |
| 1 May 2013 | Sell | 95,000 | $2.47 | 7,719,067 |
| 30 Apr 2013 | Sell | 95,000 | $2.40 | 7,719,067 |
| 29 Apr 2013 | Sell | 135,000 | $2.47 | 7,909,067 |
| 28 Apr 2013 | Sell | 136,000 | $2.55 | 7,909,067 |
| 25 Apr 2013 | Sell | 80,000 | $2.58 | 7,909,067 |
| 24 Apr 2013 | Sell | 100,000 | $2.68 | 8,260,067 |
| 23 Apr 2013 | Sell | 82,000 | $2.58 | 8,260,067 |
| 22 Apr 2013 | Sell | 315,000 | $2.67 | 8,442,067 |
| 21 Apr 2013 | Sell | 500,000 | $3.02 | 8,442,067 |
| 16 Apr 2013 | Sell | 321,682 | $3.33 | 9,257,067 |
| 1 Apr 2013 | Sell | 7,416 | $2.15 | 9,578,749 |
| 27 Mar 2013 | Sell | 10,000 | $2.20 | 9,586,165 |
| 25 Mar 2013 | Sell | 27,000 | $2.15 | 9,596,165 |
| 21 Mar 2013 | Sell | 12,554 | $2.21 | 9,596,165 |
| 20 Mar 2013 | Sell | 86,000 | $2.24 | 9,635,719 |
| 19 Mar 2013 | Sell | 17,215 | $2.34 | 9,635,719 |
Institutional Holders
| % Shares Owned: | 93.83% |
| # of Holders: | 59 |
| Total Shares Held: | 43,512,689 |
| 3 Mo. Net Change: | -1,759,358 |
| # New Positions: | 7 |
| # Closed Positions: | 6 |
| # Increased Positions: | 25 |
| # Reduced Positions: | 18 |
| # Net Buyers: | 7 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Robert Jones |
54 | 2011 | President, Chief Executive Officer, Director |
Peter Clemens |
60 | 2004 | Chief Financial Officer, Senior Vice President, Secretary |
Robert Seiser |
49 | 2004 | Vice President, Corporate Controller and Treasurer |
J. Bradley Rivet |
59 | 2011 | Vice President - Marketing |
Albert Brzeczko |
56 | 2009 | Vice President -Technical Affairs |
James Emigh |
57 | 2011 | Vice President - Corporate Development |
George Ross |
71 | 2008 | Independent Director |
William Skelly |
62 | 2000 | Independent Director |
Immanuel Thangaraj |
42 | 2002 | Independent Director |
Bruce Wesson |
70 | 1998 | Independent Director |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
